The Rationale Behind the New Alzheimer’s Disease Conceptualization: Lessons Learned During the Last Decades

Increased Cortical Thickness and Caudate Volume Precede Atrophy in PSEN1 Mutation Carriers

(2017) Juan Fortea et al.   JOURNAL OF ALZHEIMERS DISEASE

Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit

(2016) José L. Molinuevo et al.   Alzheimers & Dementia

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

(2016) Bruno Dubois et al.   Alzheimers & Dementia

Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease

(2016) Juan Domingo Gispert et al.   Alzheimers & Dementia

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

(2016) Marc Suárez‐Calvet et al.   EMBO Molecular Medicine

Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a ‘European ADNI study’

(2016) S. Galluzzi et al.   JOURNAL OF INTERNAL MEDICINE

Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases

(2016) Raffaele Ferrari et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

(2016) Bob Olsson et al.   LANCET NEUROLOGY

CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD

(2016) Juan Domingo Gispert et al.   NEUROBIOLOGY OF AGING

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

(2016) Clifford R. Jack et al.   NEUROLOGY

CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study

(2015) Michael Ewers et al.   Alzheimers & Dementia

Evolving brain structural changes in PSEN1 mutation carriers

(2015) Roser Sala-Llonch et al.   NEUROBIOLOGY OF AGING

Nonlinear cerebral atrophy patterns across the Alzheimer's disease continuum: impact of APOE4 genotype

(2015) J.D. Gispert et al.   NEUROBIOLOGY OF AGING

Cerebrospinal Fluid Biomarkers Predict Clinical Evolution in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment

(2015) Alba Sierra-Rio et al.   Neurodegenerative Diseases

The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative

(2014) José Luis Molinuevo et al.   Alzheimers & Dementia

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

(2014) Frank Jessen et al.   Alzheimers & Dementia

Time course of brain volume changes in the preclinical phase of Alzheimer's disease

(2014) Charlotte Bernard et al.   Alzheimers & Dementia

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

(2014) Bruno Dubois et al.   LANCET NEUROLOGY

Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging

(2013) Keith A. Johnson et al.   Alzheimers & Dementia

Establishing the motivations of patients with dementia and cognitive impairment and their carers in joining a dementia research register (DemReg)

(2013) Cerian Avent et al.   INTERNATIONAL PSYCHOGERIATRICS

Preface

(2013) José L. Molinuevo et al.   MEDICAL CLINICS OF NORTH AMERICA

Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease

(2013) M. Ewers et al.   NEUROLOGY

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

(2012) Susan M. Landau et al.   ANNALS OF NEUROLOGY

CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings

(2012) T. T. Seppala et al.   NEUROLOGY

Amyloid-  assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study

(2012) P. M. Doraiswamy et al.   NEUROLOGY

Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI

(2011) Leslie M. Shaw et al.   ACTA NEUROPATHOLOGICA

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

Cognitively Preserved Subjects with Transitional Cerebrospinal Fluid ß-Amyloid 1-42 Values Have Thicker Cortex in Alzheimer's Disease Vulnerable Areas

(2011) Juan Fortea et al.   BIOLOGICAL PSYCHIATRY

Applying the new research diagnostic criteria: MRI findings and neuropsychological correlations of prodromal AD

(2011) Lorena Rami et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

(2011) Christopher M. Clark   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

PICOGEN: experiencia de 5 años de un programa de asesoramiento genético en demencia

(2010) J. Fortea et al.   NEUROLOGIA

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY

Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

(2009) Tero Tapiola et al.   ARCHIVES OF NEUROLOGY

Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau181P

(2009) Karen Koopman et al.   NEUROCHEMISTRY INTERNATIONAL

Disclosure ofAPOEGenotype for Risk of Alzheimer's Disease

(2009) Robert C. Green et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration

(2008) Albert Lladó et al.   JOURNAL OF NEUROLOGY

First demonstrated de novo insertion in the prion protein gene in a young patient with dementia

(2008) R. Sanchez-Valle et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Functional connectivity of the hippocampus in elderly with mild memory dysfunction carrying the APOE ɛ4 allele

(2007) David Bartrés-Faz et al.   NEUROBIOLOGY OF AGING

Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease

(2007) Cristina Solé-Padullés et al.   NEUROBIOLOGY OF AGING